Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Inv. presentation
Appointed director
FEMASYS INC (FEMY) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/11/2023 8-K Quarterly results
10/03/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Opinion of Dechert LLP"
10/03/2023 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
09/27/2023 8-K Quarterly results
08/10/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/10/2023 8-K Quarterly results
08/07/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
08/03/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "- First of its kind, non-surgical, permanent birth control option begins enrollment in landmark trial -"
07/28/2023 PRE 14A Form PRE 14A - Other preliminary proxy statements:
07/27/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "- FemBloc ® patent application provides additional coverage for Femasys’ therapeutic option for women seeking permanent birth control -"
07/17/2023 EFFECT Form EFFECT - Notice of Effectiveness:
07/14/2023 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
07/07/2023 S-1/A Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
06/08/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Femasys’ FemCath Intrauterine Catheter Receives Product Approval in Canada"
06/02/2023 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing  Interact...
05/16/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
05/15/2023 ARS Form ARS - Annual Report to Security Holders:
05/15/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
05/11/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/11/2023 8-K Quarterly results
Docs: "Femasys Inc. Announces Financial Results for the First Quarter Ended",
"Femasys Inc. Corporate Presentation dated May 2023"
05/05/2023 PRE 14A Form PRE 14A - Other preliminary proxy statements:
05/04/2023 8-K Quarterly results
04/27/2023 10-K/A Annual Report for the period ended December 31, 2022 [amend]
04/20/2023 8-K Quarterly results
04/20/2023 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
04/18/2023 8-K Quarterly results
04/05/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
03/31/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Femasys Inc. Corporate Presentation dated March 2023"
03/30/2023 10-K Annual Report for the period ended December 31, 2022
03/30/2023 8-K Quarterly results
03/13/2023 8-K Other Events  Interactive Data
12/21/2022 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Femasys Inc. Announces Commercial Availability of its FemCath Intrauterine Device"
10/20/2022 8-K Quarterly results
10/12/2022 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "FEMASYS INC. ANNOUNCES THE APPOINTMENT OF CHRISTINE THOMAS AS SENIOR VICE PRESIDENT OF REGULATORY AND CLINICAL AFFAIRS"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy